Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632
Clinical trial NCT02779140 · COMPLETED
Trial details
- NCT number
- NCT02779140
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-05-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.